Related content

Prognostic and therapeutic implications of mTORC1 and Rictor expression in human breast cancer

By          

Oncology Reports, Vol. 29, Iss. 5, 2013-01 ,pp. : 1969-1974

Spandidos Publications

Access to resources Recommend Favorite

Serum and glucocorticoid-regulated kinase 1 (SGK1) activation in breast cancer: requirement for mTORC1 activity associates with ER-alpha expression

By Hall Ben  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 469-479

Springer Publishing Company

Access to resources Recommend Favorite

Recent Developments in Anti-Cancer Agents Targeting PI3K, Akt and mTORC1/2

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 210-236

Bentham Science Publishers

Access to resources Recommend Favorite

Aberrant differentiation of Tsc2-deficient teratomas associated with activation of the mTORC1-TFE3 pathway

By                  

Oncology Reports, Vol. 34, Iss. 5, 2015-01 ,pp. : 2251-2258

Spandidos Publications

Access to resources Recommend Favorite

Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK–mTORC1 signaling

By Fumarola Claudia   Caffarra Cristina   Monica Silvia   Galetti Maricla   Alfieri Roberta   Cavazzoni Andrea   Galvani Elena   Generali Daniele   Petronini Pier   Bonelli Mara  

Breast Cancer Research and Treatment, Vol. 141, Iss. 1, 2013-08 ,pp. : 67-78

Springer Publishing Company

Access to resources Recommend Favorite